Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies.

Autor: Rudofsky G; Private Practice for Endocrinology, Diabetes and Obesity, Olten, Switzerland. gottfried.rudofsky@hin.ch., Amadid H; Novo Nordisk A/S, Søborg, Denmark., Braae UC; Novo Nordisk A/S, Søborg, Denmark., Catrina SB; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Center for Diabetes, Academic Specialist Center, Stockholm, Sweden., Kick A; Primary Care Group Practice Sanacare, Lugano, Switzerland., Mandavya K; Novo Nordisk Service Centre India Pvt Ltd, Bangalore, India., Roslind K; Aarup Health Center I/S, Aarup, Denmark., Saravanan P; Warwick Medical School and Centre for Global Health, Warwick Academic Health, University of Warwick, Coventry, UK.; Department of Diabetes, Endocrinology and Metabolism, George Eliot Hospital, Nuneaton, UK., van Houtum W; Department of Internal Medicine, Spaarne Ziekenhuis Hoofddorp, Hoofddorp, The Netherlands., Jain AB; Division of Endocrinology and Metabolism, University of British Columbia, Vancouver, Canada.

Publikováno v: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2024 Nov 13. Date of Electronic Publication: 2024 Nov 13.

PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice.

Autor: Yabe D; Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Department of Diabetes, Endocrinology and Metabolism and Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan.; Center for One Medicine Innovative Translational Research, Gifu University, Gifu, Japan.; Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kyoto, Japan., Hamamoto Y; Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kyoto, Japan.; Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan., Kawanami D; Department of Endocrinology and Diabetes, Fukuoka University School of Medicine, Fukuoka, Japan., Nishimura R; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan., Terauchi Y; Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University, Yokohama, Japan., Amadid H; Global Clinical Drug Development, Novo Nordisk A/S, Søborg, Denmark., Braae UC; Real-World Science, Novo Nordisk A/S, Søborg, Denmark., Major-Pedersen A; Global Safety, Novo Nordisk A/S, Søborg, Denmark., Suzuki R; Department of Diabetes, Metabolism and Endocrinology, Tokyo Medical University, Tokyo, Japan.

Publikováno v: Journal of diabetes investigation [J Diabetes Investig] 2024 Nov; Vol. 15 (11), pp. 1566-1577. Date of Electronic Publication: 2024 Aug 22.

Exercise in newly diagnosed patients with multiple myeloma: A randomized controlled trial of effects on physical function, physical activity, lean body mass, bone mineral density, pain, and quality of life.

Autor: Larsen RF; Department of Physiotherapy and Occupational Therapy, Zealand University Hospital, Roskilde, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Haematology, Odense University Hospital, Odense, Denmark., Jarden M; Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Minet LR; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Geriatric, Odense University Hospital, Odense, Denmark.; The Competence Centre for Rehabilitation - KCR, Odense University Hospital, Odense, Denmark., Frølund UC; Department of Haematology, Zealand University Hospital, Roskilde, Denmark., Hermann AP; Department of Endocrinology, Odense University Hospital, Odense, Denmark., Breum L; Department of Medicine and Endocrinology, Zealand University Hospital, Koge, Denmark., Möller S; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; OPEN, Open Patient data Explorative Network, Odense University Hospital, Odense, Denmark., Abildgaard N; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Haematology, Odense University Hospital, Odense, Denmark.; The Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark.

Publikováno v: European journal of haematology [Eur J Haematol] 2024 Sep; Vol. 113 (3), pp. 298-309. Date of Electronic Publication: 2024 May 08.

Nationwide implementation of lenalidomide maintenance in multiple myeloma: A retrospective, real-world study.

Autor: Harsløf M; Department of Hematology Rigshospitalet Copenhagen Denmark.; Biotech Research and Innovation Centre University of Copenhagen Kobenhavn Denmark., Chanchiri I; Department of Hematology Odense University Hospital Odense Denmark., Silkjær T; Department of Hematology Aarhus University Hospital Aarhus Denmark., Frølund UC; Department of Hematology Zealand University Hospital Roskilde Denmark., Teodorescu EM; Department of Hematology Aalborg University Hospital Aalborg Denmark., Nielsen KB; Department of Hematology Regionshospitalet Gødstrup Herning Denmark., Nielsen PI; Department of Hematology Esbjerg Hospital Esbjerg Denmark., Pedersen PT; Department of Hematology Esbjerg Hospital Esbjerg Denmark., Iversen KF; Department of Hematology Vejle Hospital Vejle Denmark., Lund T; Department of Hematology Odense University Hospital Odense Denmark., Grønbæk K; Department of Hematology Rigshospitalet Copenhagen Denmark.; Biotech Research and Innovation Centre University of Copenhagen Kobenhavn Denmark., Thorsteinsdottir S; Department of Hematology Rigshospitalet Copenhagen Denmark., Vangsted A; Department of Hematology Rigshospitalet Copenhagen Denmark., Szabo AG; Department of Hematology Rigshospitalet Copenhagen Denmark.; Department of Hematology Vejle Hospital Vejle Denmark.

Publikováno v: EJHaem [EJHaem] 2024 Mar 27; Vol. 5 (2), pp. 316-324. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).

Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study.

Autor: Ogoina D; Infectious Diseases Unit, Department of Internal Medicine, Niger Delta University Teaching Hospital, Niger Delta University, Yenagoa, Bayelsa, Nigeria. Electronic address: dimieogoina@gmail.com., Dalhat MM; Infectious Diseases Control Centre, Kaduna, Kaduna, Nigeria., Denue BA; Department of Medicine, University of Maiduguri, Borno, Nigeria., Okowa M; Department of Public Health, Ministry of Health, Asaba, Delta, Nigeria., Chika-Igwenyi NM; Infectious Diseases Unit, Internal Medicine Department, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Ebonyi , Nigeria., Yusuff HA; Department of Public Health, Ministry of Health, Abeokuta, Ogun, Nigeria., Christian UC; Infectious Diseases and Tropical Medicine Unit, Department of Internal Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Anambra, Nigeria., Adekanmbi O; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria., Ojimba AO; Centre for Communicable Disease Control and Research, Federal Medical Centre, Asaba, Delta, Nigeria., Aremu JT; Infectious Diseases Unit, Federal Teaching Hospital Gombe, Gombe, Nigeria., Habila KL; Kaduna State Emergency Medical Services and Ambulance System, Kaduna, Kaduna, Nigeria., Oiwoh SO; Department of Internal Medicine, Irrua Specialist Teaching Hospital, Irrua, Edo, Nigeria., Tobin EA; Institute of Viral Haemorrhagic Fever and Emerging Pathogens, Irrua Specialist Teaching Hospital, Irrua, Edo, Nigeria., Johnson SM; Department of Internal Medicine, Federal University Teaching Hospital, Owerri, Imo, Nigeria., Olaitan A; Department of Internal Medicine, Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun, Nigeria., Onyeaghala C; Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers, Nigeria., Gomerep SS; Infectious Diseases Unit, Jos University Teaching Hospital, and Medicine Department, University of Jos, Plateau, Nigeria., Alasia D; Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers, Nigeria., Onukak AE; Department of Internal Medicine, University of Uyo, Uyo, Nigeria., Mmerem J; Infectious Disease and Tropical Medicine Unit, Department of Medicine, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria., Unigwe U; Infectious Disease and Tropical Medicine Unit, Department of Medicine, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria., Falodun O; Department of Internal Medicine, National Hospital Abuja, Federal Capital Territory, Nigeria., Kwaghe V; Department of Internal Medicine, University of Abuja Teaching Hospital, Gwagalada, Abuja, Federal Capital Territory, Nigeria., Awang SK; Infectious Diseases Unit, Department of Internal Medicine, Modibo Adama University Teaching Hospital, Yola, Adamawa, Nigeria., Sunday M; Department of Public Health, Federal Medical Centre, Ebute Metta, Lagos, Nigeria., Maduka CJ; Department of Internal Medicine, Federal Medical Centre, Umahia, Abia, Nigeria., Na'uzo AM; Department of Paediatrics, Federal Medical Centre, Birnin Kebbi, Kebbi, Nigeria., Owhin SO; Department of Medicine, Clinical Haematology Unit, Federal Medical Center, Owo, Ondo, Nigeria., Mohammed AA; Infectious Diseases and Tropical Medicine Unit, Ahmadu Bello University Teaching Hospital, Shika-Zaria, Kaduna, Nigeria., Adeiza MA; Infectious Diseases and Tropical Medicine Unit, Ahmadu Bello University Teaching Hospital, Shika-Zaria, Kaduna, Nigeria.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Dec; Vol. 23 (12), pp. 1418-1428. Date of Electronic Publication: 2023 Aug 22.